Adenovirus-mediated Overexpression of FcγRIIB Attenuates Pulmonary Inflammation and Fibrosis
Zhe Zhang,Zhujie Cao,Lin Hou,Meiyue Song,Yitian Zhou,Yiling Chen,Huiyuan Hu,Yangfeng Hou,Ying Liu,Bolun Li,Xiaomin Song,Weipeng Ge,Baicun Li,Xuehan Jiang,Jie Yang,Dingyun Song,Xinri Zhang,Junling Pang,Tiantian Zhang,Hong Zhang,Peiran Yang,Jing Wang,Chen Wang
DOI: https://doi.org/10.1165/rcmb.2022-0056oc
IF: 7.748
2023-02-01
American Journal of Respiratory Cell and Molecular Biology
Abstract:Progressive fibrosing interstitial lung diseases (PF-ILDs) result in high mortality and lack effective therapies. The pathogenesis of PF-ILDs involves macrophages driving inflammation and irreversible fibrosis. Fc-γ receptors (FcγRs) regulate macrophages and inflammation, but their roles in PF-ILDs remain unclear. We characterized the expression of FcγRs and found upregulated FcγRIIB in human and mouse lungs after exposure to silica. FcγRIIB deficiency aggravated lung dysfunction, inflammation, and fibrosis in silica-exposed mice. Using single-cell transcriptomics and <i>in vitro</i> experiments, FcγRIIB was found in alveolar macrophages, where it regulated the expression of fibrosis-related genes <i>Spp1</i> and <i>Ctss</i>. In mice with macrophage-specific overexpression of FcγRIIB and in mice treated with adenovirus by intratracheal instillation to upregulate FcγRIIB, silica-induced functional and histological changes were ameliorated. Our data from three genetic models and a therapeutic model suggest that FcγRIIB plays a protective role that can be enhanced by adenoviral overexpression, representing a potential therapeutic strategy for PF-ILDs.
biochemistry & molecular biology,cell biology,respiratory system